Income Statement | 2025-06-30 | |||
---|---|---|---|---|
Income tax expense | - | |||
Loss on extinguishment of debt | -4,835 | |||
Gain on extinguishment of debt | - | |||
Change in fair value of convertible bridge loans | - | |||
Amortization of debt discount | -51,006 | |||
Interest expense | -225,566 | |||
Total other expense | -281,407 | |||
Consulting and advisory fees | 327,991 | |||
Research and development expense | 69,274 | |||
Related party consulting fees | 438,000 | |||
Professional fees | 221,119 | |||
General and administrative expenses | 309,107 | |||
Total operating expenses | -1,365,491 | |||
Loss from operations | -1,365,491 | |||
Net loss before income tax expense | -1,646,898 | |||
Net loss | -1,646,898 | |||
Less net loss attributable to noncontrolling interest | 17,207 | |||
Net loss attributable to common stockholders | -1,629,691 | |||
Net loss per common share - basic and diluted | - | |||
Weighted average number of common shares outstanding - basic and diluted | 620,875,226 |
XERIANT, INC. (XERI)
XERIANT, INC. (XERI)